SMMNY - The Siemens Healthineers Is Looking Better And Better

• Fiscal first quarter results were boosted by strong contributions from rapid antigen testing, but mixed core results were still better than peer results.
• The Imaging business looks poised to go from strength to strength with very strong new product ramps and supply woes at rivals.
• I'd like to see more energy spent improving the diagnostics business, as this has been one of the few lagging major businesses at Siemens Healthineers over the years.
• This company looks set to generate top-quartile growth among large-cap med-techs over the next three to five years, and I believe the Street will reward the stock as that happens.

For further details see: